Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001104659-25-102037·Astria Therapeutics, Inc.
Schedule 13D ownership disclosure
ASTRIA THERAPEUTICS INC
Common Stock, par value $0.001 per share · CUSIP: 04635X102
Event date: 2025-10-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Magnetar Financial LLCReported CIK 0001352851
Shares: 3,312,202.00 · Class: 5.87%
- Magnetar Capital Partners LPReported CIK 0001353085
Shares: 3,312,202.00 · Class: 5.87%
- Supernova Management LLCReported CIK 0001368026
Shares: 3,312,202.00 · Class: 5.87%
- David J. SnydermanReported CIK 0001953511
Shares: 3,312,202.00 · Class: 5.87%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-102037
- Form type
- SCHEDULE 13D
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Oct 24, 2025
- Reporting period
- Oct 17, 2025
- Description
- Schedule 13D beneficial ownership